Abiopharma

🔍 Rubino Andrew J (Executive)

Company: TFS Financial CORP (TFSL)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Sold 6,600 shares of Common Stock at $15.18 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 21,310.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-06 | Code: H | nature_of_ownership: ESOP | shares_owned_after: 13,887.00 | Footnotes: F2
• Holds 14,300 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-06 | Code: H | shares_owned_after: 14,300.00 | Footnotes: F3, F4, F4
• Holds 2,167 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-06 | Code: H | shares_owned_after: 2,167.00 | Footnotes: F3, F5, F5
• Holds 5,800 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-06 | Code: H | shares_owned_after: 5,800.00 | Footnotes: F3, F6, F6
• Holds 9,800 shares of Performance Restricted Share Units (Derivative)
  Date: 2026-05-06 | Code: H | shares_owned_after: 9,800.00 | Footnotes: F3, F7, F7
• Holds 11,000 shares of Employee Stock Option (right to buy) at $14.74 per share (Derivative)
  Date: 2026-05-06 | Code: H | Expires: 2028-01-05 | shares_owned_after: 11,000.00 | Footnotes: F8

Footnotes:

• F1: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 6, 2026. The actual sale prices ranged from a low of $15.11 to a high of $15.25, inclusive. Each reporting person undertakes to provide upon request of the SEC Staff, TFS Financial Corporation or any security holder of TFS Financial Corporation full information regarding the number of shares sold at each price within the range. The amount reflected has been rounded to 2 decimal points.
• F2: Reflects transactions not required to be reported under Section 16 of the Securities Exchange Act, as amended.
• F3: Each restricted and performance stock unit represents a contingent right to receive one share of TFS Financial Corporation common stock. Restricted and performance stock units are entitled to dividend equivalent rights in the form of a cash payment in the amount of any cash dividend paid per share of common stock.
• F4: On December 18, 2025, the reporting person received a grant of 14,300 Restricted Stock Units (RSUs). These RSUs vest in three equal annual installments beginning December 10, 2026.
• F5: On March 4, 2024, the reporting person received a grant of 6,500 Restricted Stock Units (RSUs). These RSUs vest in three equal annual installments beginning December 10, 2024.
• F6: On December 19, 2024, the reporting person received a grant of 8,700 Restricted Stock Units (RSUs). These RSUs vest in three equal annual installments beginning December 10, 2025.
• F7: On November 25, 2025, the reporting person achieved performance level of 100% on a target award of 9,800 Performance Share Units ("PSUs"), resulting in a total earned award of 9,800 shares. This represents the final determination a March 4, 2024 award that was dependent on certain performance results during the two fiscal year period ended September 30, 2025. Each PSU represents a contingent right to receive one share of TFS Financial Corporation common stock and are entitled to dividend equivalent rights in the form of a cash payment in the amount of any cash dividend paid per share of common stock during the period the award was outstanding. The shares and dividend equivalent payment will vest and distribute to the reporting person on December 10, 2026.
• F8: On January 5, 2018, the reporting person received a grant of 11,000 stock options. These options will fully vest on December 10, 2020